HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Riederer Selected Research

Drug Therapy (Chemotherapy)

1/202345 years German Society of Biological Psychiatry (DGBP).
10/2017Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
3/2010[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
9/2002Degeneration of neuronal cells due to oxidative stress--microglial contribution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Riederer Research Topics

Disease

39Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2000
23Alzheimer Disease (Alzheimer's Disease)
01/2017 - 07/2000
10Dementia (Dementias)
08/2011 - 06/2000
10Infections
01/2007 - 08/2000
9Neurodegenerative Diseases (Neurodegenerative Disease)
04/2008 - 01/2000
8HIV Infections (HIV Infection)
01/2017 - 01/2000
7Amyloid Plaque
11/2006 - 09/2000
4Mitochondrial Diseases (Mitochondrial Disease)
10/2021 - 04/2000
4AIDS Dementia Complex
06/2004 - 03/2002
4Panic Disorder (Panic Attack)
11/2002 - 07/2000
3Schizophrenia (Dementia Praecox)
12/2006 - 06/2000
3Body Weight (Weight, Body)
01/2001 - 01/2000
2Mental Disorders (Mental Disorder)
01/2023 - 06/2000
2Neuroinflammatory Diseases
10/2021 - 01/2017
2Major Depressive Disorder (Major Depressive Disorders)
10/2017 - 06/2003
2Disease Progression
01/2007 - 05/2005
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2005 - 09/2002
2Neurologic Manifestations (Neurological Manifestations)
06/2004 - 03/2002
2Dyskinesias (Dyskinesia)
03/2003 - 01/2003
2Parkinsonian Disorders (Parkinsonism)
12/2002 - 01/2001
2Cognitive Dysfunction
06/2000 - 02/2000
1Pain (Aches)
03/2016
1Facial Pain (Myofacial Pain)
03/2016
1Pathologic Processes
04/2015
1Asymptomatic Infections
06/2010
1Headache (Headaches)
09/2007
1Hypertension (High Blood Pressure)
01/2007
1Diabetes Mellitus
01/2007

Drug/Important Bio-Agent (IBA)

13Dopamine (Intropin)FDA LinkGeneric
10/2021 - 01/2000
12IronIBA
10/2021 - 01/2000
9AntioxidantsIBA
04/2015 - 07/2000
7Proteins (Proteins, Gene)FDA Link
12/2004 - 03/2000
7Levodopa (L Dopa)FDA LinkGeneric
10/2004 - 05/2002
6neuromelaninIBA
12/2013 - 12/2001
6Monoamine Oxidase (MAO)IBA
03/2010 - 01/2000
6Selegiline (E250)FDA LinkGeneric
03/2004 - 01/2000
5Free RadicalsIBA
11/2006 - 04/2000
5Advanced Glycation End ProductsIBA
09/2002 - 07/2000
4Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2017 - 12/2000
4Streptozocin (Streptozotocin)FDA Link
01/2017 - 03/2004
4Glucose (Dextrose)FDA LinkGeneric
01/2017 - 06/2001
4Dopamine Agonists (Dopamine Agonist)IBA
10/2004 - 01/2003
3Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2017 - 05/2002
3Dopamine Receptors (Dopamine Receptor)IBA
01/2017 - 10/2003
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2008 - 10/2004
3alpha-SynucleinIBA
01/2007 - 12/2000
3Dopamine Agents (Dopaminergic Agents)IBA
01/2007 - 02/2001
3Neuroprotective AgentsIBA
02/2003 - 01/2000
3Amyloid beta-PeptidesIBA
12/2001 - 07/2000
3Apolipoproteins E (ApoE)IBA
09/2001 - 06/2000
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
05/2001 - 01/2000
2Glutathione (Reduced Glutathione)IBA
10/2021 - 10/2001
2Antidepressive Agents (Antidepressants)IBA
10/2017 - 06/2003
2Neurotrophin 3IBA
10/2017 - 10/2001
2Insulin ReceptorIBA
01/2017 - 04/2015
2Chelating AgentsIBA
04/2015 - 07/2000
2Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
04/2015 - 08/2004
2N-Methylaspartate (NMDA)IBA
03/2010 - 01/2007
2Melanins (Melanin)IBA
06/2009 - 02/2005
2Nerve Growth Factors (Neurotrophins)IBA
01/2008 - 10/2001
2UbiquitinIBA
01/2008 - 10/2004
2Neurotransmitter Agents (Neurotransmitter)IBA
03/2007 - 06/2004
2Glutamic Acid (Glutamate)FDA Link
11/2006 - 01/2000
2Biomarkers (Surrogate Marker)IBA
01/2005 - 08/2000
2Thioctic Acid (Lipoic Acid)IBA
03/2004 - 06/2001
2Cyclic AMP (AMP, Cyclic)IBA
06/2003 - 12/2000
2Tolcapone (Tasmar)FDA Link
02/2003 - 05/2002
2ropinirole (Requip)FDA LinkGeneric
10/2002 - 09/2000
2CalciumIBA
10/2001 - 03/2000
2ApolipoproteinsIBA
09/2001 - 11/2000
2Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
01/2001 - 08/2000
2NeurotoxinsIBA
01/2001 - 04/2000
1SynucleinsIBA
10/2021
1Serotonin (5 Hydroxytryptamine)IBA
10/2017
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2017
1Insulin (Novolin)FDA Link
01/2017
13' Untranslated Regions (3' UTR)IBA
01/2017
1Type A Botulinum Toxins (Botox)FDA Link
03/2016
1Formaldehyde (Formol)FDA Link
03/2016
1ChemokinesIBA
07/2015
1Transcription Factors (Transcription Factor)IBA
07/2015
1PPAR gammaIBA
07/2015
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2015
1Oxyquinoline (8 Hydroxyquinoline)FDA Link
04/2015
1CatalaseIBA
04/2015
1biotinylated dextran amine (B-DA)IBA
06/2010
1Amantadine (Aman)FDA LinkGeneric
03/2010
1Memantine (Namenda)FDA Link
03/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2010
1AntibodiesIBA
06/2009
1CytokinesIBA
01/2008
1Glutamate Receptors (Glutamate Receptor)IBA
01/2008
15-HT1A Serotonin ReceptorIBA
09/2007
15-HT1B Serotonin ReceptorIBA
09/2007
1Antihypertensive Agents (Antihypertensives)IBA
01/2007
1Methylphenidate (Ritalin)FDA LinkGeneric
12/2006
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2006

Therapy/Procedure

11Therapeutics
01/2023 - 01/2000
4Drug Therapy (Chemotherapy)
01/2023 - 09/2002
1Nursing Care
08/2011